TrialJAMA cardiology2018

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Benjamin M Scirica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.